AuditLine › HHS OIG › Centers for Medicare and Medicaid Services
HHS OIG recommendation 23-A-04-118.05
We recommend that the Alabama Medicaid Agency work with CMS to determine and refund the unallowable portion of Federal reimbursement for…
The recommendation, in the publisher's words
We recommend that the Alabama Medicaid Agency work with CMS to determine and refund the unallowable portion of Federal reimbursement for physician-administered drugs that were not invoiced for rebates after December 31, 2019.
- Responsible agency
- Centers for Medicare and Medicaid Services
- Issued
- September 21, 2023
- Report
- Alabama Did Not Always Invoice Rebates to Manufacturers for Pharmacy and Physician-Administered Drugs (A-04-21-08090) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- October 8, 2025 (publisher's date)
- Publisher topics
- Financial Stewardship, Prescription Drug
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
5 more, of which 0 are open in the publisher's file.
- We recommend that the Alabama Medicaid Agency refund to the Federal Government $14,960,673 (Federal share) for claims for single-source physician-administered drugs that were ineligible…HHS OIG 23-A-04-118.01 · issued Sep 21, 2023 · closed Oct 8, 2025Closed Implemented
- We recommend that the Alabama Medicaid Agency refund to the Federal Government $43,981 (Federal share) for claims for top-20 multiple-source physician-administered drugs that were…HHS OIG 23-A-04-118.02 · issued Sep 21, 2023 · closed Oct 8, 2025Closed Implemented
- We recommend that the Alabama Medicaid Agency work with CMS to determine and refund the unallowable portion of $290,455 (Federal share) for other claims for multiple-source…HHS OIG 23-A-04-118.03 · issued Sep 21, 2023 · closed Oct 8, 2025Closed Implemented
- We recommend that the Alabama Medicaid Agency complete the process for rebating pharmacy drugs totaling $6,568 ($4,719 Federal share) for single-source and $219,220 ($157,395 Federal…HHS OIG 23-A-04-118.04 · issued Sep 21, 2023 · closed Oct 8, 2025Closed Implemented
- We recommend that the Alabama Medicaid Agency strengthen its internal controls to ensure that all pharmacy and physician-administered drugs eligible for rebates are invoiced.HHS OIG 23-A-04-118.06 · issued Sep 21, 2023 · closed Oct 8, 2025Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.